Cell Bio Human Tech Co.,Ltd Statistics

Total Valuation

Cell Bio Human Tech Co.,Ltd has a market cap or net worth of KRW 28.96 billion. The enterprise value is 18.99 billion.

Market Cap	28.96B
Enterprise Value	18.99B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Cell Bio Human Tech Co.,Ltd has 8.78 million shares outstanding. The number of shares has increased by 3.79% in one year.

Current Share Class	n/a
Shares Outstanding	8.78M
Shares Change (YoY)	+3.79%
Shares Change (QoQ)	+4.90%
Owned by Insiders (%)	37.53%
Owned by Institutions (%)	4.22%
Float	5.02M

Valuation Ratios

The trailing PE ratio is 20.21.

PE Ratio	20.21
Forward PE	n/a
PS Ratio	1.02
PB Ratio	0.65
P/TBV Ratio	0.67
P/FCF Ratio	3.50
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.94, with an EV/FCF ratio of 2.30.

EV / Earnings	13.44
EV / Sales	0.68
EV / EBITDA	3.94
EV / EBIT	6.21
EV / FCF	2.30

Financial Position

The company has a current ratio of 3.47, with a Debt / Equity ratio of 0.12.

Current Ratio	3.47
Quick Ratio	2.69
Debt / Equity	0.12
Debt / EBITDA	1.16
Debt / FCF	0.67
Interest Coverage	6.79

Financial Efficiency

Return on equity (ROE) is 3.12% and return on invested capital (ROIC) is 3.73%.

Return on Equity (ROE)	3.12%
Return on Assets (ROA)	3.60%
Return on Capital (ROIC)	3.73%
Revenue Per Employee	471.47M
Profits Per Employee	23.95M
Employee Count	59
Asset Turnover	0.52
Inventory Turnover	2.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.92% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-18.92%
50-Day Moving Average	3,485.60
200-Day Moving Average	3,729.58
Relative Strength Index (RSI)	45.44
Average Volume (20 Days)	31,344

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cell Bio Human Tech Co.,Ltd had revenue of KRW 27.82 billion and earned 1.41 billion in profits. Earnings per share was 163.26.

Revenue	27.82B
Gross Profit	7.77B
Operating Income	3.06B
Pretax Income	2.76B
Net Income	1.41B
EBITDA	4.82B
EBIT	3.06B
Earnings Per Share (EPS)	163.26

Full Income Statement

Balance Sheet

The company has 15.99 billion in cash and 5.57 billion in debt, giving a net cash position of 10.42 billion or 1,187.40 per share.

Cash & Cash Equivalents	15.99B
Total Debt	5.57B
Net Cash	10.42B
Net Cash Per Share	1,187.40
Equity (Book Value)	45.15B
Book Value Per Share	5,093.09
Working Capital	18.40B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.16 billion and capital expenditures -895.95 million, giving a free cash flow of 8.26 billion.

Operating Cash Flow	9.16B
Capital Expenditures	-895.95M
Free Cash Flow	8.26B
FCF Per Share	941.70

Full Cash Flow Statement

Margins

Gross margin is 27.92%, with operating and profit margins of 10.99% and 5.08%.

Gross Margin	27.92%
Operating Margin	10.99%
Pretax Margin	9.91%
Profit Margin	5.08%
EBITDA Margin	17.32%
EBIT Margin	10.99%
FCF Margin	29.71%

Dividends & Yields

Cell Bio Human Tech Co.,Ltd does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.79%
Shareholder Yield	-3.79%
Earnings Yield	4.95%
FCF Yield	28.54%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cell Bio Human Tech Co.,Ltd has an Altman Z-Score of 4.3.

Altman Z-Score	4.3
Piotroski F-Score	n/a